Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2005
03/08/2005US6864268 Antidiabetic agents
03/08/2005US6864266 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
03/08/2005US6864265 Chemokine receptor binding heterocyclic compounds
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864261 Substituted piperzino-pyridine compound, useful for treting pain, anxiety, urinary incontinence, an addictive disorder, Parkinson's disease, epilepsy, psychosis, and used as Selective antagonists of the metabotropic glutamate receptor 5
03/08/2005US6864260 Inhibit p38- alpha kinase using compounds of the formula and the pharmaceutically acceptable salts thereof, or a pharmaceutical composition thereof, wherein noninterfering substituent;
03/08/2005US6864255 Substituted triazinyl amide derivatives and methods of use
03/08/2005US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer
03/08/2005CA2261680C Fluorine-containing 1,4-disubstituted piperidine derivatives
03/03/2005WO2005019207A1 Fungicidal pyrimidine derivatives
03/03/2005WO2005019206A1 Mitotic kinesin inhibitors
03/03/2005WO2005019205A1 Mitotic kinesin inhibitors
03/03/2005WO2005019204A1 A process for the preparation of cilostazol and of the intermediates thereof
03/03/2005WO2005019203A1 Haloalkyl- and piperidine-substituted benzimidazole-derivatives
03/03/2005WO2005019202A1 Substituted pyrimdinone derivatives and methods of use
03/03/2005WO2005019200A2 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof
03/03/2005WO2005019177A1 Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof
03/03/2005WO2005019176A1 Substituted amino-aza-cyclohexanes
03/03/2005WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase
03/03/2005WO2005019168A2 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
03/03/2005WO2005019167A2 Melanin concentrating hormone receptor antagonist
03/03/2005WO2005019163A2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
03/03/2005WO2005019147A2 Pesticidally active phenol derivatives
03/03/2005WO2005018557A2 Substituted pyridinones
03/03/2005WO2005018531A2 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
03/03/2005WO2004101553B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
03/03/2005WO2004083173A3 Ketopiperazine derivatives as bradykinin antagonists
03/03/2005WO2004001058A3 Transcription factor modulating compounds and methods of use thereof
03/03/2005US20050049413 Quinoline derivatives
03/03/2005US20050049290 Benzimidazole derivatives and their use as gnrh antagonists
03/03/2005US20050049288 5-MEMBERED HETEROCYCLE-BASED p38 KINASE INHIBITORS
03/03/2005US20050049282 Process
03/03/2005US20050049280 e.g., ethyl 4-(hydroxyaminocarbonyl)-4-[4-(p-trifluoromethylphenoxy)piperidin-1-ylsulfonyl]piperidine-N-carboxylate
03/03/2005US20050049277 Histamine H3 receptor antagonists; such as 2-(4-(n-ethyl)anilinoethoxyphenyl)imidazo[1,2-a]pyridine
03/03/2005US20050049274 Selective, potent small molecule protein tyrosine kinase inhibitors; such as 6-chloro-3-(3-methyl-isoxazol-5-yl)-4-(pyridin-4-yl)-1H-quinolin-2-one
03/03/2005US20050049269 For therapy of metabolic and eating disorders
03/03/2005US20050049268 Use of at least one abl, kit and/or platelet-derived growth factor receptor tyrosine kinases inhibitor for treating hair depigmentation
03/03/2005US20050049264 Suppressing growth of abnormal cells; gastric, brain, colon, pancreatic, lung, renal, ovarian and prostatic cancer
03/03/2005US20050049257 e.g., 5-[6-(dimethylamino)-4-methylpyridin-3-yl]-N-[(1R,2S)-2ethoxy-2,3-dihydro-1H-inden-1-yl]-3,6-diethylpyrazin-2-amine; used in treating anxiety disorders, depression and stress related disorders
03/03/2005US20050049253 Substituted quinolinone derivatives and methods of use
03/03/2005US20050049252 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors
03/03/2005US20050049247 Pyrimidines useful as modulators of voltage-gated ion channels
03/03/2005US20050049244 osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis
03/03/2005US20050049240 Tetrahydroisochinolines, their production and the use thereof as analgesics
03/03/2005US20050049237 Pyrazole-amides and -sulfonamides
03/03/2005CA2536313A1 Fused pyrimidine derivative and use thereof
03/03/2005CA2535644A1 Substituted pyrimdinone derivatives and methods of use
03/03/2005CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase
03/03/2005CA2533112A1 Melanin concentrating hormone receptor antagonist
03/02/2005EP1510516A1 Pyrazole compound and medicinal composition containing the same
03/02/2005EP1510515A1 Phenylglycine derivatives as serine protease inhibitors
03/02/2005EP1509574A1 Yellow anionic disazo dyes
03/02/2005EP1509537A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
03/02/2005EP1509518A1 Calcium receptor modulating agents
03/02/2005EP1509516A1 Inhibitors of the gpib -vwf interaction, their preparation and use
03/02/2005EP1509507A2 Mitotic kinesin inhibitors
03/02/2005EP1509506A1 Pyridazine derivatives
03/02/2005EP1509505A2 SMALL MOLECULE MODULATORS OF THE 5−HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO
03/02/2005EP1509499A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005EP1509491A1 Intermediate products, methods for their preparation and use thereof
03/02/2005EP1509226A2 Small molecule inhibitors of her2 expression
03/02/2005EP1509219A1 Methods and compositions for the treatment of graft failure
03/02/2005EP1509218A1 Peptide deformylase inhibitors
03/02/2005EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction
03/02/2005EP1278741B1 Muscarinic agonists
03/02/2005EP1241943B1 Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same
03/02/2005EP1180102B9 Mutual prodrugs of amlodipine and atorvastatin
03/02/2005EP1042279B1 Substituted beta-alanines
03/02/2005EP1014976B1 Novel substituted imidazole compounds
03/02/2005EP0919553B1 cis-SUBSTITUTED AMINOCYCLOPROPANE DERIVATIVES
03/02/2005EP0871448B1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase
03/02/2005EP0824530B1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
03/02/2005CN1589270A Indole-2-formamide compounds as factor Xa inhibitors
03/02/2005CN1589269A Heteroindanes: a new class of potent cannabimimetic ligands
03/02/2005CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
03/02/2005CN1589260A Heterocyclic compounds and methods of use thereof
03/02/2005CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists
03/02/2005CN1587263A Novel pyrimidyl sulfamide compounds with anti-tumor activity and their salts
03/02/2005CN1191252C 3-position substituted quinolone derivativers and its use in pharmacy
03/02/2005CN1191249C Quinoline and quinazoline compound for treating benign prostatic hyperplasia specially
03/02/2005CN1191247C Substituted guanidine derivatives
03/02/2005CN1191246C Indolylpiperidine derivatives as antihistaminic and antiallergic agents
03/02/2005CN1191245C Substitued cyclobutylamine derivatives
03/02/2005CN1191239C Pyrazole derivatives for the treatment of viral diseases
03/02/2005CN1191233C N-substituted nitrogen heterocyclic compound
03/01/2005US6861530 Piperidine derivatives
03/01/2005US6861529 Cycloalkylpyrrole-3-carboxylic acid amide derivatives and heterocycloalkylpyrrole-3-carboxylic acid amide derivatives that bind with high affinity to the benzodiazepine site of GABA-A (gamma-aminobutyric acid) receptors
03/01/2005US6861448 Nictoinamide adenine dinucleotide (NAD); microbiocides; antiseptics; plant safening agents; antibiotic resistance; agriculture; food treatment
03/01/2005US6861440 Antidiabetic agents
03/01/2005US6861433 Oxazolidinone photoaffinity probes
03/01/2005US6861432 Piperazine derivatives that destabilize androgen receptors
03/01/2005US6861425 Benzimidazole compounds as ORL1-receptor agonists
03/01/2005US6861424 A piperazine compound as antithrombotic agent
03/01/2005US6861421 Nociceptin analogs
03/01/2005US6861420 N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds
03/01/2005US6861418 Modulating protein kinase signal transduction; anticancer agents
03/01/2005US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis
03/01/2005US6861409 Compounds for use in the dtreatment of growth metabolic disorders
03/01/2005US6861162 Organic electroluminescence devices using pyrazolo[3,4b]quinoxaline derivatives
1 ... 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 ... 1080